|
2016 Journal Article Performance analysis of solar cogeneration system with different integration strategies for potable water and domestic hot water productionKumar, N. T. Uday, Mohan, Gowtham and Martin, Andrew (2016). Performance analysis of solar cogeneration system with different integration strategies for potable water and domestic hot water production. Applied Energy, 170, 466-475. doi: 10.1016/j.apenergy.2016.02.033 |
|
2016 Journal Article Benefit of treatment of latent tuberculosis infection in individual patientsDobler, Claudia C., Martin, Andrew and Marks, Guy B. (2016). Benefit of treatment of latent tuberculosis infection in individual patients. The European respiratory journal, 47 (5), 1594-1595. doi: 10.1183/13993003.00175-2016 |
|
2016 Journal Article A novel solar thermal polygeneration system for sustainable production of cooling, clean water and domestic hot water in United Arab Emirates: Dynamic simulation and economic evaluationMohan, Gowtham, Kumar, Uday, Pokhrel, Manoj Kumar and Martin, Andrew (2016). A novel solar thermal polygeneration system for sustainable production of cooling, clean water and domestic hot water in United Arab Emirates: Dynamic simulation and economic evaluation. Applied Energy, 167, 173-188. doi: 10.1016/j.apenergy.2015.10.116 |
|
2016 Journal Article Perioperative management of diabetes in elective patients: A region-wide auditJackson, M. J., Patvardhan, C., Wallace, F., Martin, A., Yusuff, H., Briggs, G. and Malik, R. A. (2016). Perioperative management of diabetes in elective patients: A region-wide audit. British Journal of Anaesthesia, 116 (4), 501-506. doi: 10.1093/bja/aev554 |
|
2016 Conference Publication Permanently grafted abrasion resistant nanocomposites for anti-icing applicationsGao, Jing, Martin, Andrew, Yatvin, Jeremy and Locklin, Jason (2016). Permanently grafted abrasion resistant nanocomposites for anti-icing applications. WASHINGTON: AMER CHEMICAL SOC. |
|
2016 Journal Article The authors replyChen, Andrew C., Martin, Andrew J. and Damian, Diona L. (2016). The authors reply. New England Journal of Medicine, 374 (8). doi: 10.1056/NEJMc1514791 |
|
2016 Journal Article Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinomaHong, Angela, Zhang, Xiaoying, Jones, Deanna, Veillard, Anne-Sophie, Zhang, Mei, Martin, Andrew, Lyons, J. Guy, Lee, C. Soon and Rose, Barbara (2016). Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma. Radiotherapy and Oncology, 118 (2), 342-349. doi: 10.1016/j.radonc.2016.02.009 |
|
2016 Journal Article Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniquesDuchesne, Gillian M., Haworth, Annette, Bone, Eric, Carter, Hannah, Ebert, Martin A., Gagliardi, Frank, Gibbs, Adrian, Hornby, Colin, Martin, Andrew, Sidhom, Mark, Wood, Maree and Jackson, Michael (2016). Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology, 60 (1), 129-137. doi: 10.1111/1754-9485.12390 |
|
2016 Journal Article Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: A longitudinal cohort studyKennedy, N. J., Peek, M. J., Quinton, A. E., Lanzarone, V., Martin, A., Benzie, R. and Nanan, R. (2016). Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: A longitudinal cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 123 (2), 225-232. doi: 10.1111/1471-0528.13758 |
|
2016 Journal Article A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipientsChen, A. C., Martin, A. J., Dalziell, R. A., McKenzie, C. A., Lowe, P. M., Eris, J. M., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Bielski, V. A., Halliday, G. M. and Damian, D. L. (2016). A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. British Journal of Dermatology, 175 (5), 1073-1075. doi: 10.1111/bjd.14662 |
|
2015 Journal Article The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trialRoberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Perkovic, Vlado, Scaria, Anish, Tonkin, Andrew M., Vergara, Liza A., Hawley, Carmel M., BLOCADE Study Collaborative Group, Reidlinger, Donna, Tan, Ken-Soon and Martin, Andrew (2015). The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial. American Journal of Kidney Diseases, 67 (6), 902-911. doi: 10.1053/j.ajkd.2015.10.029 |
|
2015 Journal Article BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301)Hayne, Dickon, Stockler, Martin, McCombie, Steve P., Chalasani, Venu, Long, Anne, Martin, Andrew, Sengupta, Shomik and Davis, Ian D. (2015). BCG+MMC trial: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: A randomised phase III trial (ANZUP 1301). BMC Cancer, 15 (1) 432. doi: 10.1186/s12885-015-1431-6 |
|
2015 Journal Article Benefit of treatment of latent tuberculosis infection in individual patientsDobler, Claudia C., Martin, Andrew and Marks, Guy B. (2015). Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal, 46 (5), 1397-1406. doi: 10.1183/13993003.00577-2015 |
|
2015 Conference Publication ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERSMartin, Andrew (2015). ANALYSING THE EVIDENCE - THE STATISTICS OF SMALL NUMBERS. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304)Davis, Ian, Stockler, Martin, Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Yip, Sonia, Dazo, Carlo, Long, Anne, Lawrence, Nicky, Chan, Howard, McDermott, Ray, Chowdhury, Simon, Marchesin, Vittorio, Deignan, Olwyn, Parulekar, Wendy, Suris, Alexander Montenegro and Sweeney, Christopher (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: THE ANZUP ENZAMET TRIAL (ANZUP 1304). HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501Grummet, Jeremy, Davis, Ian, Martin, Andrew, Buchan, Nicholas, Chalasani, Venu, Frydenberg, Mark, Hayne, Dickon, Lalak, Andre, Patel, Manish, Williams, Andrew, Woo, Henry, Lawrence, Nicola, Chan, Howard, Bishop, Claudia, Wong, Nicole, Coskinas, Xanthi and Stockler, Martin (2015). RANDOMISED PHASE 3 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHOXYFLURANE WITH PERIPROSTATIC LOCAL ANAESTHESIA TO REDUCE THE DISCOMFORT OF TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY (PAIN-FREE TRUS B): ANZUP 1501. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303)Williams, Scott G., Davis, Ian D., Sweeney, Christopher, Stockler, Martin R., Martin, Andrew, Hague, Wendy, Coskinas, Xanthi, Long, Anne, Yip, Sonia, Tu, Emily, Chan, Howard, Lawrence, Nicky, McDermott, Ray, Hughes, Simon, Marchesin, Vittorio, Deignan, Olwyn and Nguyen, Paul L. (2015). RANDOMISED PHASE 3 TRIAL OF ENZALUTAMIDE IN ANDROGEN DEPRIVATION THERAPY WITH RADIATION THERAPY FOR HIGH RISK, CLINICALLY LOCALISED, PROSTATE CANCER: ENZARAD (ANZUP 1303). HOBOKEN: WILEY-BLACKWELL. |
|
2015 Conference Publication RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301)Chalasani, Venu, Sengupta, Shomik, Stockler, Martin, McCombie, Steve, Hawks, Cynthia, Krieger, Laurence, Anderson, Paul, Grummet, Jeremy, Mitterdorfer, Andrew J., Bishop, Conrad, Beardsley, Emma, Martin, Andrew, Lawrence, Nicola, Wong, Nicole, Chan, Howard, Pysarenko, Mariya, Harper, Matthew, Patel, Manish, Hamid, Akil, Davis, Ian and Hayne, Dickon (2015). RANDOMISED PHASE 3 TRIAL OF THE ADDITION OF MITOMYCIN TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER(ANZUP 1301). HOBOKEN: WILEY-BLACKWELL. |
|
2015 Journal Article A phase 3 randomized trial of nicotinamide for skin-cancer chemopreventionChen, Andrew C., Martin, Andrew J., Choy, Bonita, Fernandez-Penas, Pablo, Dalziell, Robyn A., McKenzie, Catriona A., Scolyer, Richard A., Dhillon, Haryana M., Vardy, Janette L., Kricker, Anne, George, Gayathri St., Chinniah, Niranthari, Halliday, Gary M. and Damian, Diona L. (2015). A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 373 (17), 1618-1626. doi: 10.1056/NEJMoa1506197 |
|
2015 Conference Publication Discussing and prescribing expensive unfunded anticancer drugs in AustraliaKarikios, D., Mileshkin, L., Martin, A., Ferraro, D. and Stockler, M. (2015). Discussing and prescribing expensive unfunded anticancer drugs in Australia. European Cancer Congress, Vienna Austria, 2015. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(16)30506-8 |
